ARTICLE | Clinical News
ASN100: Phase I started
December 7, 2015 8:00 AM UTC
Arsanis began an Austrian Phase I trial of ASN100 in healthy volunteers. ASN100 was discovered under a deal with Adimab, which is using its technology to discover and optimize mAbs against targets des...